Shopping Cart
- Remove All
- Your shopping cart is currently empty
CGP-20712 is a selective β 1-adrenoceptor antagonist with an IC50 of 0.7 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $350 | In Stock | |
5 mg | $828 | In Stock | |
10 mg | $1,130 | In Stock | |
25 mg | $1,590 | In Stock | |
50 mg | $1,980 | In Stock | |
100 mg | $2,500 | In Stock | |
500 mg | $4,900 | In Stock |
Description | CGP-20712 is a selective β 1-adrenoceptor antagonist with an IC50 of 0.7 nM. |
Targets&IC50 | β2-adrenoceptor:6700 nM, β1-adrenoceptor:0.7 nM |
In vitro | In brown adipocytes, CGP-20712 (1 μM) significantly inhibited UCP1 gene expression induced by NE. However, CGP-20712 had no effect on lipolysis. These results suggested that β1-adrenoceptor mediated UCP1 gene expression.[4] In neocortical membranes, CGP 20712 exhibited affinity for β1-adrenoceptor and β2-adrenoceptor with IC50 values of 0.7 and 6700 nM, respectively.[1] |
In vivo | CGP 20712 (a selective beta 1-adrenergic receptor antagonist) (5 mg/kg; Pretreatment of 8-day-old rats) did not change the plasma ACTH response to insulin injection.[3] |
Alias | UNII-SIO2UEZ19H, CGP 20712 |
Molecular Weight | 494.46 |
Formula | C23H25F3N4O5 |
Cas No. | 137888-49-4 |
Smiles | CN1C(=NC(C(F)(F)F)=C1)C2=CC=C(OCC(CNCCOC3=CC(C(N)=O)=C(O)C=C3)O)C=C2 |
Relative Density. | 1.40 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (91.01 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.